• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

FDA approves new drug application for Pliaglis

Article

The Food and Drug Administration has approved a supplemental new drug application for Pliaglis (lidocaine 7 percent, tetracaine 7 percent), a topical anesthetic cream.

Recent Videos
Related Content
Sanofi Reports High Efficacy in Dupilumab for BP

Sanofi Reports High Efficacy in Dupilumab for BP

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
Research Highlights Disparities in Melanoma Knowledge and Care

Research Highlights Disparities in Melanoma Knowledge and Care

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Nearly half of FDA-authorized AI tools may be ineffective

Nearly half of FDA-authorized AI tools may be ineffective

Article
CG and Minoxidil Combination Therapy Shows Promise for AA

CG and Minoxidil Combination Therapy Shows Promise for AA

Article
© 2024 MJH Life Sciences

All rights reserved.